{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:24:40Z","timestamp":1789878280669,"version":"4.0.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T00:00:00Z","timestamp":1518998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81572273"],"award-info":[{"award-number":["No. 81572273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81602015"],"award-info":[{"award-number":["No. 81602015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical Science and Technology Project of Jiangsu Province","award":["No. BL2013026"],"award-info":[{"award-number":["No. BL2013026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s12094-018-1838-z","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T06:23:41Z","timestamp":1519021421000},"page":"1168-1174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Frequent genomic alterations and better prognosis among young patients with non-small-cell lung cancer aged 40\u00a0years or younger"],"prefix":"10.1007","volume":"20","author":[{"given":"X.","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4979-4131","authenticated-orcid":false,"given":"Y.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,19]]},"reference":[{"key":"1838_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx030","author":"A Jemal","year":"2017","unstructured":"Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson B, et al. Annual report to the nation on the status of cancer, 1975\u20132014, featuring survival. J Natl Cancer Inst. 2017. \n                    https:\/\/doi.org\/10.1093\/jnci\/djx030\n                    \n                  .","journal-title":"J Natl Cancer Inst."},{"issue":"1","key":"1838_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7\u201330. \n                    https:\/\/doi.org\/10.3322\/caac.21387\n                    \n                  .","journal-title":"CA Cancer J Clin"},{"key":"1838_CR3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21338","author":"WZR Chen","year":"2016","unstructured":"Chen WZR, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016. \n                    https:\/\/doi.org\/10.3322\/caac.21338\n                    \n                  .","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1838_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/JTO.0b013e3181c41e8d","volume":"5","author":"J Subramanian","year":"2010","unstructured":"Subramanian J, Morgensztern D, Goodgame B, Baggstrom MQ, Gao F, Piccirillo J, et al. Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis. J Thorac Oncol. 2010;5(1):23\u20138. \n                    https:\/\/doi.org\/10.1097\/JTO.0b013e3181c41e8d\n                    \n                  .","journal-title":"J Thorac Oncol."},{"key":"1838_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fonc.2015.00113","volume":"5","author":"A Thomas","year":"2015","unstructured":"Thomas A, Chen Y, Yu T, Jakopovic M, Giaccone G. Trends and characteristics of young non-small cell lung cancer patients in the United States. Front Oncol. 2015;5:113. \n                    https:\/\/doi.org\/10.3389\/fonc.2015.00113\n                    \n                  .","journal-title":"Front Oncol."},{"issue":"10","key":"1838_CR6","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/cncr.30539","volume":"123","author":"K Tanaka","year":"2017","unstructured":"Tanaka K, Hida T, Oya Y, Yoshida T, Shimizu J, Mizuno T, et al. Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma. Cancer. 2017;123(10):1731\u201340. \n                    https:\/\/doi.org\/10.1002\/cncr.30539\n                    \n                  .","journal-title":"Cancer"},{"issue":"3","key":"1838_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1001\/jamaoncol.2015.4482","volume":"2","author":"AG Sacher","year":"2016","unstructured":"Sacher AG, Dahlberg SE, Heng J, Mach S, Janne PA, Oxnard GR. Association between younger age and targetable genomic alterations and prognosis in non-small-cell lung cancer. Jama Oncol. 2016;2(3):313\u201320. \n                    https:\/\/doi.org\/10.1001\/jamaoncol.2015.4482\n                    \n                  .","journal-title":"Jama Oncol."},{"issue":"2","key":"1838_CR8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.lungcan.2014.04.007","volume":"85","author":"MS Lara","year":"2014","unstructured":"Lara MS, Brunson A, Wun T, Tomlinson B, Qi L, Cress R, et al. Predictors of survival for younger patients less than 50\u00a0years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis. Lung Cancer. 2014;85(2):264\u20139. \n                    https:\/\/doi.org\/10.1016\/j.lungcan.2014.04.007\n                    \n                  .","journal-title":"Lung Cancer."},{"issue":"7","key":"1838_CR9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMc1415359","volume":"372","author":"AT Shaw","year":"2015","unstructured":"Shaw AT, Solomon BJ. Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med. 2015;372(7):683\u20134. \n                    https:\/\/doi.org\/10.1056\/NEJMc1415359\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"9","key":"1838_CR10","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1093\/annonc\/mdv270","volume":"26","author":"YL Wu","year":"2015","unstructured":"Wu YL, Zhou C, Liam CK, Wu G, Liu X, Zhong Z, et al. First-line erlotinib versus gemcitabine\/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study. Ann Oncol. 2015;26(9):1883\u20139. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdv270\n                    \n                  .","journal-title":"Ann Oncol."},{"issue":"23","key":"1838_CR11","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","volume":"371","author":"BJ Solomon","year":"2014","unstructured":"Solomon BJ, Mok T, Kim DW, Wu YL, Nakagawa K, Mekhail T, et al. First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med. 2014;371(23):2167\u201377. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1408440\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"25","key":"1838_CR12","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","volume":"362","author":"M Maemondo","year":"2010","unstructured":"Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med. 2010;362(25):2380\u20138. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0909530\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"1838_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/1471-2407-12-241","volume":"12","author":"CL Hsu","year":"2012","unstructured":"Hsu CL, Chen KY, Shih JY, Ho CC, Yang CH, Yu CJ, et al. Advanced non-small cell lung cancer in patients aged 45\u00a0years or younger: outcomes and prognostic factors. BMC Cancer. 2012;12:241. \n                    https:\/\/doi.org\/10.1186\/1471-2407-12-241\n                    \n                  .","journal-title":"BMC Cancer."},{"issue":"7","key":"1838_CR14","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.jtho.2016.03.023","volume":"11","author":"BN Arnold","year":"2016","unstructured":"Arnold BN, Thomas DC, Rosen JE, Salazar MC, Blasberg JD, Boffa DJ, et al. Lung cancer in the very young: treatment and survival in the national cancer data base. J Thorac Oncol. 2016;11(7):1121\u201331. \n                    https:\/\/doi.org\/10.1016\/j.jtho.2016.03.023\n                    \n                  .","journal-title":"J Thorac Oncol."},{"issue":"15","key":"1838_CR15","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1002\/cncr.25100","volume":"116","author":"J Zhang","year":"2010","unstructured":"Zhang J, Chen SF, Zhen Y, Xiang J, Wu C, Bao P, et al. Multicenter analysis of lung cancer patients younger than 45\u00a0years in Shanghai. Cancer. 2010;116(15):3656\u201362. \n                    https:\/\/doi.org\/10.1002\/cncr.25100\n                    \n                  .","journal-title":"Cancer"},{"issue":"11","key":"1838_CR16","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/qjmed\/hcv052","volume":"108","author":"AL Rich","year":"2015","unstructured":"Rich AL, Khakwani A, Free CM, Tata LJ, Stanley RA, Peake MD, et al. Non-small cell lung cancer in young adults: presentation and survival in the english national lung cancer audit. QJM. 2015;108(11):891\u20137. \n                    https:\/\/doi.org\/10.1093\/qjmed\/hcv052\n                    \n                  .","journal-title":"QJM"},{"key":"1838_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.lungcan.2016.05.020","volume":"98","author":"YM Chen","year":"2016","unstructured":"Chen YM, Lai CH, Rau KM, Huang CH, Chang HC, Chao TY, et al. Advanced non-small cell lung cancer patients at the extremes of age in the era of epidermal growth factor receptor tyrosine kinase inhibitors. Lung Cancer. 2016;98:99\u2013105. \n                    https:\/\/doi.org\/10.1016\/j.lungcan.2016.05.020\n                    \n                  .","journal-title":"Lung Cancer."},{"key":"1838_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.lungcan.2016.04.022","volume":"97","author":"S Scarpino","year":"2016","unstructured":"Scarpino S, Rampioni Vinciguerra GL, Di Napoli A, Fochetti F, Uccini S, Iacono D, et al. High prevalence of ALK+\/ROS1+ cases in pulmonary adenocarcinoma of adolescents and young adults. Lung Cancer. 2016;97:95\u20138. \n                    https:\/\/doi.org\/10.1016\/j.lungcan.2016.04.022\n                    \n                  .","journal-title":"Lung Cancer."},{"issue":"1","key":"1838_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3978\/j.issn.2072-1439.2012.12.02","volume":"5","author":"O Nagashima","year":"2013","unstructured":"Nagashima O, Ohashi R, Yoshioka Y, Inagaki A, Tajima M, Koinuma Y, et al. High prevalence of gene abnormalities in young patients with lung cancer. J Thorac Dis. 2013;5(1):27\u201330. \n                    https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2012.12.02\n                    \n                  .","journal-title":"J Thorac Dis."},{"key":"1838_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.lungcan.2017.08.022","volume":"113","author":"L Corrales-Rodriguez","year":"2017","unstructured":"Corrales-Rodriguez L, Arrieta O, Mas L, Baez-Saldana R, Castillo-Fernandez O, Blais N, et al. An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP). Lung Cancer. 2017;113:30\u20136. \n                    https:\/\/doi.org\/10.1016\/j.lungcan.2017.08.022\n                    \n                  .","journal-title":"Lung Cancer."},{"key":"1838_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.lungcan.2016.04.004","volume":"96","author":"F Hsu","year":"2016","unstructured":"Hsu F, De Caluwe A, Anderson D, Nichol A, Toriumi T, Ho C. EGFR mutation status on brain metastases from non-small cell lung cancer. Lung Cancer. 2016;96:101\u20137. \n                    https:\/\/doi.org\/10.1016\/j.lungcan.2016.04.004\n                    \n                  .","journal-title":"Lung Cancer."},{"issue":"2","key":"1838_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/JTO.0000000000000069","volume":"9","author":"DY Shin","year":"2014","unstructured":"Shin DY, Na II, Kim CH, Park S, Baek H, Yang SH. EGFR mutation and brain metastasis in pulmonary adenocarcinomas. J Thorac Oncol. 2014;9(2):195\u20139. \n                    https:\/\/doi.org\/10.1097\/JTO.0000000000000069\n                    \n                  .","journal-title":"J Thorac Oncol."},{"issue":"5","key":"1838_CR23","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/neuonc\/nov266","volume":"18","author":"K Takano","year":"2016","unstructured":"Takano K, Kinoshita M, Takagaki M, Sakai M, Tateishi S, Achiha T, et al. Different spatial distributions of brain metastases from lung cancer by histological subtype and mutation status of epidermal growth factor receptor. Neuro Oncol. 2016;18(5):716\u201324. \n                    https:\/\/doi.org\/10.1093\/neuonc\/nov266\n                    \n                  .","journal-title":"Neuro Oncol."}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-018-1838-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-018-1838-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-018-1838-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T19:37:30Z","timestamp":1550518650000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-018-1838-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,19]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["1838"],"URL":"https:\/\/doi.org\/10.1007\/s12094-018-1838-z","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,19]]},"assertion":[{"value":"26 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}